Skip to content

What changed

From · resolution motion · 11 Sept 2026 B-10-2026-0392 on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products
To · Adopted text · 16 Sept 2026 TA-10-2026-0295 Maximum residue levels for flupyradifurone
The two versions differ only in presentation — cover page, numbering or the parts a report carries that the adopted text does not.
+4 added · −2 removed · 0 modified paragraphs (every paragraph that differs, packaging included)

B100392/2026

P10_TA(2026)0295

European Parliament resolution on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products (D113006/03 – 2026/2838(RPS))

Maximum residue levels for flupyradifurone

PE792.012

European Parliament resolution of 16 September 2026 on the draft Commission regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products (D113006/03 – 2026/2838(RPS))

The European Parliament,